Home » Topics » BioWorld Science

BioWorld Science
RSS

Sichuan Haisco Pharmaceutical discloses new JAK inhibitors

Jan. 24, 2022

Chinese researchers patent sigma-1 receptor agonists

Jan. 24, 2022

CDK9 inhibition as promising therapeutic strategy against HCC

Jan. 24, 2022

Endonuclease V is a diagnostic and prognostic marker in colon adenocarcinoma

Jan. 24, 2022

LBX2 is a marker of colon adenocarcinoma

Jan. 24, 2022

Tevogen to study allogeneic T-cell technology for Epstein-Barr virus and MS

Jan. 21, 2022

M1 muscarinic receptor mutant mice show accelerated prion neurodegeneration

Jan. 21, 2022

Alzinova selects humanized lead candidate of monoclonal antibody ALZ-201

Jan. 21, 2022

Macolacin, a novel naturally inspired antibiotic with efficacy against MDR pathogens

Jan. 21, 2022

4E Therapeutics discloses new MNK1 and/or MNK2 inhibitors

Jan. 21, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...